Production (Stage)
Lifevantage Corporation
LFVN
$12.66
-$0.54-4.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.13% | 31.26% | -8.08% | -9.76% | -10.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.13% | 31.26% | -8.08% | -9.76% | -10.23% |
| Cost of Revenue | 9.25% | 19.24% | -6.77% | -9.46% | -4.20% |
| Gross Profit | 24.31% | 34.54% | -8.40% | -9.83% | -11.71% |
| SG&A Expenses | 19.74% | 22.29% | -13.06% | -12.09% | -12.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.44% | 21.65% | -11.80% | -11.53% | -11.18% |
| Operating Income | 109.57% | 371.85% | 243.12% | 32.09% | 20.95% |
| Income Before Tax | 117.60% | 377.79% | 210.98% | 6.06% | 15.38% |
| Income Tax Expenses | 170.99% | 218.20% | 276.00% | 138.31% | -59.25% |
| Earnings from Continuing Operations | 109.16% | 488.72% | 190.30% | -33.62% | 62.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 109.16% | 488.72% | 190.30% | -33.62% | 62.33% |
| EBIT | 109.57% | 371.85% | 243.12% | 32.09% | 20.95% |
| EBITDA | 71.65% | 1,516.05% | 101.98% | 19.72% | 14.63% |
| EPS Basic | 110.49% | 501.54% | 199.00% | -31.64% | 64.81% |
| Normalized Basic EPS | 118.94% | 386.93% | 220.82% | 29.40% | 17.09% |
| EPS Diluted | 100.00% | 465.38% | 180.00% | -30.70% | 62.50% |
| Normalized Diluted EPS | 112.32% | 365.88% | 217.97% | 26.88% | 13.50% |
| Average Basic Shares Outstanding | -0.60% | -3.18% | -2.99% | -2.85% | -1.51% |
| Average Diluted Shares Outstanding | 2.42% | 4.48% | -2.17% | -0.87% | 1.69% |
| Dividend Per Share | 14.29% | 14.29% | 14.29% | 14.29% | 16.67% |
| Payout Ratio | -0.46% | 1.28% | -0.97% | 0.70% | -0.28% |